Becton Dickinson Expects FY2026 Adjusted EPS of $13.10–$13.30
The company expects fiscal 2026 adjusted EPS of $13.10 to $13.30, versus a FactSet estimate of $12.67.
Related stories
Godrej Agrovet Reports 24% Profit Growth as EBITDA Margin Falls to 6.7%
Godrej Agrovet reported a 24.2% year-on-year increase in net profit for the September quarter, with higher revenue across key segments. Animal Nutrition and Oil Palm supported topl
M impact | EARNINGS | Nov 06, 2026, 03:32 PM UTC
Five9 Cuts FY Adjusted Earnings Outlook, Shares Tumble 22%
Five9 cut its adjusted earnings outlook for the year and issued a forecast for the current quarter that the report described as underwhelming. Shares fell 22% to $26.72 on Friday;
M impact | EARNINGS | Nov 06, 2026, 03:13 PM UTC
JFrog Posts Blowout Earnings, With AI Coding Driving Growth
JFrog’s quarterly earnings report showed AI-driven demand supporting growth. Shares surged 31% to $9, according to the report.
M impact | EARNINGS | Nov 06, 2026, 03:04 PM UTC
Vistra Corp earnings above expectations at 3.01 USD
Vistra Corp (VST) released earnings per share at 3.01 USD, compared to market expectations of 2.40 USD.
H impact | EARNINGS | Nov 06, 2026, 03:02 PM UTC
Enbridge earnings below expectations at 0.49 CAD
Enbridge (ENB) released earnings per share at 0.49 CAD, compared to market expectations of 0.54 CAD.
H impact | EARNINGS | Nov 06, 2026, 03:01 PM UTC
Moderna Raises 2026 Revenue Growth Outlook to 15%–25%
Moderna now expects 2026 revenue growth of 15% to 25%, up from previous guidance of up to 10%, citing stronger international demand for its Covid-19 vaccines. Third-quarter revenue
M impact | EARNINGS | Nov 06, 2026, 02:55 PM UTC